A syndicate of South Korean and Chinese investors has powered Oxford Vacmedix (OVM) to a series A round. OVM will use the $12.5 million (£9 million) investment to take vaccines against cervical cancer ...
Upgrade to begin using 40 years of earnings data and get so much more. Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
* Says it lowered conversion price of 1st series convertible bonds to 5,534 won/share from 16,600 won/share, effective April 30 ...
Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback